Ohmx is a clinical diagnostic company that is developing a low-cost, bioelectronic, Point-Of-Care (POC) system that quantifies analytes from a low-volume biological sample (e.g. whole blood, urine, semen, prostatic fluid, etc). Ohmx’s market entry strategy is based on a portable analyzer to assist clinicians with the diagnosis and monitoring of patients with chronic diseases in the POL (physician office lab) setting.The Ohmx POC device will enable doctors to quickly and cost-effectively diagnose, monitor and better manage patients with chronic diseases. The company’s initial focus is on the diabetes market, starting with a POC Hemoglobin A1c test using a fingerstick blood sample.